Sign In
Buy QCLS
Tnf Pharmaceuticals . Common Stock Stock Insider Power
Based on the 35 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 2.96M and sold 0 QCLS shares in the last 35 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
100.00 |
| ● Buy | 2.96M shares |
| ● Sell | 0 shares |
|
100% Buy Activity
Negligible or No Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Apr 13, 2026 Buy |
Silverman Joshua Executive Chairman |
100 000 Value: $500.0K |
||
|
Apr 13, 2026 Buy |
Bernstein Bruce Director |
50 000 Value: $250.0K |
||
|
Apr 13, 2026 Buy |
Silverman Joshua Executive Chairman |
162 162 Value: $600.0K |
||
|
Apr 13, 2026 Buy |
White Billy Joe Director |
50 000 Value: $250.0K |
||
|
Apr 13, 2026 Buy |
Glass Mitchell Chief Medical Officer |
50 000 Value: $250.0K |
||
|
Apr 13, 2026 Buy |
Friscia Stephen Director |
50 000 Value: $250.0K |
||
|
Apr 13, 2026 Buy |
Voss Chelsea Sierra Director |
50 000 Value: $250.0K |
||
|
Mar 30, 2026 Buy |
Voss Chelsea Sierra Director |
1 753 Value: $6K |
||
|
Jan 16, 2026 Buy |
Voss Chelsea Sierra Director |
0 Value: $0 |
||
|
Jan 16, 2026 Buy |
Voss Chelsea Sierra Director |
0 Value: $0 |
||
|
Jan 16, 2026 Buy |
Voss Chelsea Sierra Director |
212 500 Value: $1.08M |
||
|
Jan 16, 2026 Buy |
Voss Chelsea Sierra Director |
212 500 Value: $901.0K |
||
|
Jan 16, 2026 Buy |
Voss Chelsea Sierra Director |
25 000 Value: $106.0K |
||
|
Nov 14, 2025 Buy |
Pharmacyte Biotech, Inc. 10 Percent Owner |
889 865 Value: $2.63M |
||
|
Nov 14, 2025 Buy |
White Billy Joe Director |
22 839 Value: $67.6K |
||
|
Nov 14, 2025 Buy |
Glass Mitchell Director, Chief Medical Off. |
11 420 Value: $33.8K |
||
|
Nov 14, 2025 Buy |
Rauch Gary M Vice President Of Finance |
11 420 Value: $33.8K |
||
|
Nov 14, 2025 Buy |
Bernstein Bruce Director |
25 000 Value: $74.0K |
||
|
Nov 14, 2025 Buy |
Friscia Stephen Director |
22 839 Value: $67.6K |
||
|
Nov 14, 2025 Buy |
Silverman Joshua Executive Chairman |
91 356 Value: $270.4K |
||
|
Oct 03, 2025 Buy |
Rauch Gary M Vice President Of Finance |
1 080 Value: $6K |
||
|
Oct 03, 2025 Buy |
White Billy Joe Director |
2 161 Value: $12.4K |
||
|
Oct 03, 2025 Buy |
Glass Mitchell Director, Chief Medical Off. |
1 080 Value: $6K |
||
|
Oct 03, 2025 Buy |
Friscia Stephen Director |
2 161 Value: $12.4K |
||
|
Oct 03, 2025 Buy |
Silverman Joshua Executive Chairman |
8 644 Value: $49.7K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
